/
PANC
$0.00+$0.00 (+0.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
Exchange
OTC Link
CS
Price (6 mo)
Loading chart…
Change+$0.00
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $40.7M | $26.9M | $4.2M | $1.1M | $1.3M | $1.0M | $284.0K | $180.0K |
| Cost of revenue | $23.7M | $15.7M | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $17.0M | $11.2M | $4.2M | $1.1M | $1.3M | $1.0M | $284.0K | $180.0K |
| Gross margin | 41.8% | 41.6% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| R&D | $17.5M | $20.2M | $21.5M | $4.5M | $11.1M | $19.8M | $24.5M | $25.1M |
| Operating income | $15.2M | $16.8M | $20.4M | $4.3M | $12.0M | $60.0M | $41.7M | $39.0M |
| EBITDA | −$10.8M | −$13.4M | −$19.4M | −$4.2M | −$11.7M | −$39.9M | −$40.9M | −$38.2M |
| Net income | −$15.0M | −$23.4M | −$20.0M | −$4.5M | −$12.0M | −$59.1M | −$38.1M | −$37.5M |
| Net margin | -36.8% | -87.1% | -474.3% | -418.2% | -900.4% | -5631.8% | -13419.0% | -20810.6% |
| EPS (diluted) | -7.50 | -10.50 | -8.80 | -1.98 | -14.51 | -1.72 | -0.75 | -0.70 |
Annual figures · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$0.27
Price
$0.00
Implied upside
+26923007%
Peer comparison
PANACOS PHARMS INC
PANACOS PHARMS INC
Held by traders on TradeandTell
No one on the platform currently holds PANC.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in PANC as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded PANC yet.